EP Patent

EP3746111B1 — Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Assigned to Novo Nordisk AS · Expires 2023-07-19 · 3y expired

What this patent protects

Patent listed against Ozempic.

Drugs covered by this patent

Patent Metadata

Patent number
EP3746111B1
Jurisdiction
EP
Classification
—
Expires
2023-07-19
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.